Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Caffeine citrate

EU orphan designation number: EU/3/03/132   
Active ingredient: Caffeine citrate
Indication: Treatment of primary apnoea of premature newborns
Sponsor: Chiesi Farmaceutici S.p.A.
Via Palermo 26/A, 43122 Parma, Italia
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Peyona on 2/07/2009 with the number EU/1/09/528

   Public summary of scientific opinion     EPAR

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/02/2003 Orphan designation EMEA/OD/047/02 (2003)610 of 17/02/2003
22/01/2007 Transfer of orphan designation EMEA/OD/047/02/T/01 (2007)195 of 19/01/2007
5/05/2009 Other procedure